Ep. 206 Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines with Dr. Todd Morgan

695.729 - 715.777 Dr. Todd Morgan

And the answer is no, as far as we can tell. Now, you know, we can talk about, you know, maybe carve-outs for patients at really high risk of recurrence who maybe were undersampled in these studies. But really, you know, waiting until biochemical recurrence is totally appropriate, saves a ton of patients from unnecessary salvage treatment. And so that's where the field has moved, right?